Dr. Alan Ken Matsumoto, MD

Dr. Matsumoto practices at Silver Spring Podiatry Center in Silver Spring, Maryland.

Dr. Matsumoto's NPI, 1043219298, was assigned on July 19, 2005. Dr. Matsumoto graduated from University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) in 1985. Dr. Matsumoto holds Maryland license D0036867.

Dr. Matsumoto's primary practice is Silver Spring Podiatry Center, at 2730 University W Blvd, Silver Spring, MD 20902 in Montgomery County. The practice phone is (301) 949-3668.

Dr. Matsumoto's primary practice is Silver Spring Podiatry Center in Silver Spring, Maryland. The medical group on file is Arthritis and Rheumatism Associates, P.C. Dmand AI also links Dr. Matsumoto to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Matsumoto practices. Vendor and product names are available with a free account.

Rheumatology is Dr. Matsumoto's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Matsumoto is licensed in Maryland.

CMS data shows 153,668 Medicare services from Dr. Matsumoto across 66 procedure codes in 2024, for 1,266 Medicare patients. Medicare paid $2,198,628 for them. Every service was in an office.

CMS counts 1,266 Medicare patients who saw Dr. Matsumoto in 2024. The largest group is 75 to 84, with 527 patients. 75% of them have arthritis, and 75% have high cholesterol. 11% are also on Medicaid. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Matsumoto's median patient age at 70, with 73% women.

In 2024, Dr. Matsumoto wrote 2,372 Medicare Part D claims for 405 patients. 87% of them were for generic drugs. CMS names the drug for 2,194 of them, across 35 drugs with 11 or more claims each, at $2,296,768 in total drug cost. In 2023, CMS named 1,812 claims across 29 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 86 out of 100 for Dr. Matsumoto for performance year 2024, reported as part of a group. Dr. Matsumoto accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Matsumoto as offering telehealth.

Dmand AI links 4 papers to Dr. Matsumoto, published from 2017 to 2023. The most frequent topics are Antirheumatic Agents, Arthritis, Rheumatoid and Double-Blind Method. Dr. Matsumoto's most frequent co-authors are Mark Christopher Genovese, MD, Alan J. Kivitz, MD and Matthew Charles Baker, MD.

Dmand AI links Dr. Matsumoto to 8 clinical trials, 4 of them phase 3 studies. Conditions studied include Arthritis, Rheumatoid, Rheumatic Diseases and Gout. GlaxoSmithKline sponsors the most, 4.

CMS Open Payments shows 936 general payments to Dr. Matsumoto from 34 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 65% of the total. Bristol-Myers Squibb Company paid the most, $72,368.

Dr. Matsumoto graduated from University of Illinois College of Med (Chi/Peor/Rock/Chm-Urb) in 1985.